Info: 48 g, Giving 60 Doses of Vanilla Flavoured Powder Per Bottle
New! An effective oral probiotic that has been clinically proven to be able to reduce the incidence and frequency of ear infections and helps to prevent infections such as sore throats (pharyngitis/tonsillitis), presented in a powdered form, ideal for kids.
Info: 48 g, Giving 60 Doses of Vanilla Flavoured Powder Per Bottle
New! An effective oral probiotic that has been clinically proven to be able to reduce the incidence and frequency of ear infections and helps to prevent infections such as sore throats (pharyngitis/tonsillitis), presented in a powdered form, ideal for kids.
Product Notes:
BLIS Probiotics Ears&Throat Kids powder with BLIS K12.
"BLIS K12" is an extensively researched type of probiotic that's naturally present healthy people's mouths which has proven to be quite effective in warding off the harmful bacteria that can cause a range of problems in the ears, nose, and throat when taken as an oral supplement.
It was discovered about 20 years ago and perfected in New Zealand to be a means of treating strep throat, and has been licensed to several different companies around the world since, but BLIS Probiotics is the originating company, which is now licensed to release it here in Canada.
The BLIS K12 strain is also featured in other BLIS Probiotics formulas including Ears & Throat and Fresh Breath. The powder is great for those (kids in particular) who might not get the full benefits from a BLIS K12 lozenge or gum (which need to stay in the mouth longer to work).
Health Canada Natural Product Number: 80104825.
Ingredients:
Medicinal Ingredient - Each dose (please use the enclosed dosing spoon to dispense the correct quantity) contains:
Streptococcus salivarius K12: 1 billion CFU (Colony Forming Units)
Non-medicinal ingredients: Isomalt, maltodextrin, natural flavour.
This product does not contain wheat, gluten, soy, eggs, tree nuts, peanuts, fish or shellfish. May contain trace amounts of milk protein from the fermentation process.
Suggested Usage:
Designed for Children 3 to 5 years, or for anyone who cannot safely suck on a lozenge (or who would prefer not to).
For general oral/throat health, take 1 to 2 doses per day, using the enclosed measuring spoon. For prevention of sore throat due to infection or otitis media, take 2 doses per day for 90 days.
To be effective, the powder should be dissolved slowly directly on the tongue, rather than immediately swallowing it. Do not mix it with hot food or with drinks.
It may be sprinkled onto cool temperature foods (such as a breakfast cereal or a jello dessert) if need be, for those might not take well to having it sprinkled on the tongue.
Unlike many types of probiotics, this type is a shelf-stable formula which does not need to be refrigerated.
Warnings:
Do not use BLIS Probiotics Ears & Throat if you have an immune-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment) or a milk/dairy allergy.
Consult a healthcare practitioner prior to use if you have fever, vomiting, bloody diarrhoea or severe abdominal pain. If symptoms of ear, nose or throat infections (e.g. fever, sore throat) develop, consult a health care practitioner.
Supporting Science:
The effectiveness and safety of S. salivarius K12 in maintaining oral health has been evaluated in over 30 clinical studies to date, just a few examples include:
*"Effectiveness of the probiotic Streptococcus salivarius K12 for the treatment and/or prevention of sore throat: a systematic review." Clinical Microbiology and Infection: The official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019.
*"Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review." Probiotics and Antimicrobial Proteins, 2017.
"Pilot study to explore the prophylactic efficacy of oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngo-tonsillar episodes in pediatric patients." International Journal of General Medicine, 2019.
"Use of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in children." Drug, Healthcare and Patient Safety 2014.